%0 Journal Article
%T A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
%A Ann E. McCullough
%A George P. Kim
%A Jeffrey P. Meyers
%A Jeffrry P. Jaffe
%A Matthew M. Ames
%A Nathan R. Foster
%A Steven R. Alberts
%A Thomas C. Smyrk
%A Thorvardur R. Halfdanarson
%J Archive of "The Oncologist".
%D 2019
%R 10.1634/theoncologist.2018-0878
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516109/